Latest Ratios: P/E Ratio 8.2x · EV/EBITDA 4.6x · ROE 32.3%. (1997–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $79M | $170M | $83M | $55M | $57M | $105M | $197M | $194M | $90M | $61M | $198M |
| Enterprise Value | $70M | $161M | $80M | $46M | $52M | $100M | $176M | $177M | $79M | $57M | $199M |
| P/E Ratio → | 8.21 | 17.21 | 27.91 | 21.75 | 18.13 | 8.17 | 17.11 | 25.96 | 15.54 | 39.36 | 33.17 |
| P/S Ratio | 0.34 | 0.74 | 0.42 | 0.26 | 0.28 | 0.48 | 0.85 | 0.86 | 0.44 | 0.31 | 0.96 |
| P/B Ratio | 2.34 | 4.90 | 3.21 | 1.58 | 1.80 | 2.85 | 5.94 | 7.15 | 4.10 | 4.21 | 16.29 |
| P/FCF | 7.49 | 16.17 | 8.38 | 14.54 | 8.84 | 16.31 | 12.62 | 12.72 | 10.46 | 11.03 | 36.10 |
| P/OCF | 6.63 | 14.30 | 6.84 | 8.01 | 7.14 | 13.18 | 10.77 | 10.93 | 6.79 | 9.27 | 32.74 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.71 | 0.40 | 0.22 | 0.25 | 0.45 | 0.76 | 0.78 | 0.39 | 0.29 | 0.96 |
| EV / EBITDA | 4.57 | 10.51 | 10.12 | 5.89 | 4.84 | 4.74 | 8.58 | 15.55 | 6.77 | 9.38 | 13.01 |
| EV / EBIT | 5.75 | 13.23 | 18.49 | 10.84 | 11.15 | 5.67 | 11.94 | 18.54 | 7.88 | 16.41 | 16.59 |
| EV / FCF | — | 15.36 | 8.05 | 12.27 | 8.15 | 15.54 | 11.28 | 11.59 | 9.16 | 10.31 | 36.38 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 80.4% | 80.4% | 79.3% | 79.7% | 81.5% | 82.7% | 83.7% | 83.2% | 82.9% | 83.2% | 83.6% |
| Operating Margin | 5.3% | 5.3% | 2.2% | 2.0% | 3.7% | 8.0% | 6.6% | 4.2% | 5.1% | 2.2% | 6.5% |
| Net Profit Margin | 4.3% | 4.3% | 1.5% | 1.2% | 1.5% | 5.9% | 5.0% | 3.3% | 2.8% | 0.8% | 2.9% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 32.3% | 32.3% | 9.7% | 7.7% | 9.1% | 36.8% | 38.2% | 30.2% | 31.6% | 12.1% | 77.9% |
| ROA | 14.8% | 14.8% | 4.6% | 3.7% | 4.2% | 18.7% | 20.2% | 14.0% | 12.0% | 3.4% | 13.2% |
| ROIC | 37.5% | 37.5% | 13.3% | 12.0% | 19.3% | 59.9% | 104.8% | 69.3% | 73.0% | 27.6% | 84.4% |
| ROCE | 29.5% | 29.5% | 10.3% | 9.3% | 15.4% | 40.3% | 49.1% | 33.6% | 41.9% | 20.4% | 73.0% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.34 | 0.34 | 0.52 | 0.38 | 0.50 | 0.49 | 0.04 | 0.05 | 0.25 | 0.51 | 0.78 |
| Debt / EBITDA | 0.76 | 0.76 | 1.72 | 1.67 | 1.45 | 0.86 | 0.06 | 0.13 | 0.46 | 1.22 | 0.61 |
| Net Debt / Equity | — | -0.25 | -0.13 | -0.25 | -0.14 | -0.14 | -0.63 | -0.64 | -0.51 | -0.28 | 0.13 |
| Net Debt / EBITDA | -0.56 | -0.56 | -0.41 | -1.09 | -0.41 | -0.24 | -1.02 | -1.53 | -0.96 | -0.66 | 0.10 |
| Debt / FCF | — | -0.81 | -0.33 | -2.26 | -0.69 | -0.78 | -1.34 | -1.14 | -1.31 | -0.73 | 0.28 |
| Interest Coverage | — | — | — | — | 470.10 | 1036.18 | 123.17 | 29.58 | 21.94 | 6.11 | 3.61 |
Net cash position: cash ($20M) exceeds total debt ($12M)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.87 | 1.87 | 1.69 | 2.26 | 1.83 | 1.91 | 1.75 | 1.65 | 1.64 | 1.52 | 1.49 |
| Quick Ratio | 1.11 | 1.11 | 1.01 | 1.44 | 1.18 | 1.27 | 1.20 | 1.12 | 1.06 | 0.81 | 0.61 |
| Cash Ratio | 0.74 | 0.74 | 0.76 | 1.10 | 0.78 | 0.92 | 0.88 | 0.72 | 0.70 | 0.49 | 0.28 |
| Asset Turnover | — | 3.18 | 3.32 | 3.23 | 2.92 | 2.80 | 3.96 | 4.09 | 3.97 | 4.41 | 4.11 |
| Inventory Turnover | 2.17 | 2.17 | 2.75 | 2.70 | 2.31 | 2.37 | 2.73 | 2.76 | 2.56 | 2.02 | 1.35 |
| Days Sales Outstanding | — | 6.28 | 5.95 | 3.17 | 9.00 | 6.57 | 4.09 | 5.33 | 4.52 | 4.11 | 2.74 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 2.6% | 1.2% | 8.3% | 2.9% | 0.7% | 0.4% | — | — | — | — | — |
| Payout Ratio | 21.1% | 21.1% | 236.3% | 62.4% | 12.1% | 2.9% | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 12.2% | 5.8% | 3.6% | 4.6% | 5.5% | 12.2% | 5.8% | 3.9% | 6.4% | 2.5% | 3.0% |
| FCF Yield | 13.3% | 6.2% | 11.9% | 6.9% | 11.3% | 6.1% | 7.9% | 7.9% | 9.6% | 9.1% | 2.8% |
| Buyback Yield | 7.4% | 3.4% | 9.2% | 1.9% | 16.0% | 8.7% | 5.9% | 4.0% | 1.7% | 0.0% | 0.0% |
| Total Shareholder Yield | 9.9% | 4.6% | 17.5% | 4.8% | 16.6% | 9.0% | 5.9% | 4.0% | 1.7% | 0.0% | 0.0% |
| Shares Outstanding | — | $13M | $13M | $13M | $13M | $14M | $15M | $15M | $14M | $14M | $15M |
Distributor Network Churn
According to current market data, LFVN trades at a P/S ratio of 0.37, which appears to reflect a significant complexity discount compared to broader packaged food peers, likely driven by investor skepticism regarding the long-term sustainability of the company's multi-level marketing revenue model and recent growth deceleration.
The forward P/E of 11.55 suggests that the market is pricing in minimal growth expectations, potentially viewing the current strategic pivot as a defensive measure rather than a catalyst for expansion. Investors should monitor whether this valuation gap narrows as the LV360 model matures or if the discount persists due to structural regulatory risks.
Based on reported financial statements, LFVN's ROIC has trended downward from 12.8% in 2025Q3 to 3.9% in 2026Q3, indicating that the company is struggling to generate meaningful returns on its invested capital as the core business model faces significant headwinds and operational transformation costs.
This decay in capital efficiency suggests that the company's investments in its sales force and digital infrastructure are not yet yielding the expected productivity gains. The volatility in ROE, which dropped to 4.1% in the most recent quarter, further underscores the difficulty in compounding value within the current high-commission, low-margin framework.
As disclosed in recent quarterly filings, the company's cash conversion cycle has expanded to 142 days in 2026Q3, primarily driven by a high days-inventory-outstanding metric of 183 days, which suggests that inventory management is becoming increasingly inefficient relative to the company's historical performance and industry standards.
The inability to optimize the cash conversion cycle may indicate that the company is holding excess stock to support distributor demand that is not materializing as expected. This inefficiency ties up liquidity that could otherwise be deployed to support the LV360 transition, potentially limiting management's strategic flexibility.
Based on the latest quarterly data, LFVN maintains a disciplined debt-to-equity ratio of 0.31, which provides a necessary financial buffer against the volatility inherent in the direct-selling business model and the ongoing strategic pivot, despite the company's persistent accumulation of negative retained earnings over time.
While the low leverage is a positive indicator of financial health, the lack of interest coverage data suggests that the company's ability to service debt remains sensitive to operating margin fluctuations. Investors should monitor whether this conservative stance is maintained if the company requires additional capital to fund its digital transformation.
Market participants frequently misapply the 80% gross margin as a proxy for product pricing power, when in reality, this metric is a structural requirement of the MLM commission model rather than an indicator of competitive advantage or superior brand equity in the broader consumer defensive sector.
Focusing on gross margin obscures the reality that the majority of this spread is immediately consumed by distributor incentives, leaving very little operating margin for the company. Analysts should instead prioritize operating margin and distributor retention rates to better assess the true earning power and long-term viability of the business.
Includes 30+ ratios · 29 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying LFVN stock.
LifeVantage Corporation's current P/E ratio is 8.2x. The historical average is 22.2x. This places it at the 14th percentile of its historical range.
LifeVantage Corporation's current EV/EBITDA is 4.6x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 16.3x.
LifeVantage Corporation's return on equity (ROE) is 32.3%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 7.2%.
Based on historical data, LifeVantage Corporation is trading at a P/E of 8.2x. This is at the 14th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
LifeVantage Corporation's current dividend yield is 2.55% with a payout ratio of 21.1%.
LifeVantage Corporation has 80.4% gross margin and 5.3% operating margin.
LifeVantage Corporation's Debt/EBITDA ratio is 0.8x, indicating low leverage. A ratio below 2x is generally considered financially healthy.